Ai Can Call The Shots On Drug Making Because It 'doesn't Have A Career At Stake,' Major Pharma Ceo Says

Paul Hudson, CEO of Sanofi, said the pharmaceutical company uses AI to help recommend which drugs to move forward with on development.Jemal Countess/Getty Images for Fortune MediaSanofi's CEO said the pharma firm uses AI to help decide to move a drug to the next developmental phase.He said it's a "sobering" process because AI agents have no careers at stake."The agent isn't wedded to the project for 10 years," Paul Hudson said at Davos.Paul Hudson, CEO of the pharmaceutical firm Sanofi, has an argument for letting AI make top-level decisions in medicine: It has no attachments.Speaking at a panel in Davos on Tuesday, Hudson said Sanofi uses AI to recommend whether drugs should "pass through a tollgate," or essentially get approval to move to the next phase of development.He said that when Sanofi's senior decision-makers convene to discuss a drug, they start with an AI's recommendation for their choice."And we do that because it's very sobering, because the agent doesn't have a career at stake," Hudson said.